Literature DB >> 23649462

Functional and molecular imaging of localized and recurrent prostate cancer.

Kinzya Grant1, Maria L Lindenberg, Haytham Shebel, Yuxi Pang, Harsh K Agarwal, Marcelino Bernardo, Karen A Kurdziel, Baris Turkbey, Peter L Choyke.   

Abstract

Prostate cancer is the most common malignancy among American men. Imaging of localized and recurrent prostate cancer is challenging since conventional imaging techniques are limited. New imaging techniques such as multiparametric MRI and PET with targeted tracers have been investigated extensively in the last decade. As a result, the role of novel imaging techniques for the detection of localized and recurrent prostate cancer has recently expanded. In this review, novel functional and molecular imaging techniques used in the management of localized and recurrent prostate cancer are discussed.

Entities:  

Mesh：

Year:  2013        PMID： 23649462      PMCID： PMC6330105          DOI： 10.1007/s00259-013-2419-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


  74 in total

1.  Initial results of 3-dimensional 1H-magnetic resonance spectroscopic imaging in the localization of prostate cancer at 3 Tesla: should we use an endorectal coil?

Authors:  Derya Yakar; Stijn W T P J Heijmink; Christina A Hulsbergen-van de Kaa; Henkjan Huisman; Jelle O Barentsz; Jurgen J Fütterer; Tom W J Scheenen
Journal:  Invest Radiol       Date:  2011-05       Impact factor: 6.016

2.  The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.

Authors:  Ryogo Minamimoto; Hiroji Uemura; Futoshi Sano; Hideyuki Terao; Yoji Nagashima; Shoji Yamanaka; Kazuya Shizukuishi; Ukihide Tateishi; Yoshinobu Kubota; Tomio Inoue
Journal:  Ann Nucl Med       Date:  2010-10-08       Impact factor: 2.668

3.  The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.

Authors:  Karen A Kurdziel; Joanna H Shih; Andrea B Apolo; Liza Lindenberg; Esther Mena; Yolanda Y McKinney; Stephen S Adler; Baris Turkbey; William Dahut; James L Gulley; Ravi A Madan; Ola Landgren; Peter L Choyke
Journal:  J Nucl Med       Date:  2012-06-22       Impact factor: 10.057

4.  Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

Authors:  Masato Shiiba; Keiichi Ishihara; Go Kimura; Tomoyuki Kuwako; Hisashi Yoshihara; Naohisa Yoshihara; Hidetaka Sato; Yukihiro Kondo; Shin-ichi Tsuchiya; Shin-ichiro Kumita
Journal:  Ann Nucl Med       Date:  2011-11-09       Impact factor: 2.668

5.  Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Authors:  David M Schuster; John R Votaw; Peter T Nieh; Weiping Yu; Jonathon A Nye; Viraj Master; F DuBois Bowman; Muta M Issa; Mark M Goodman
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

6.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging.

Authors:  Stefano Cirillo; Massimo Petracchini; Lorenza Scotti; Teresa Gallo; Annalisa Macera; Maria Cristina Bona; Cinzia Ortega; Pietro Gabriele; Daniele Regge
Journal:  Eur Radiol       Date:  2008-09-30       Impact factor: 5.315

Review 7.  Multiparametric MRI and prostate cancer diagnosis and risk stratification.

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Curr Opin Urol       Date:  2012-07       Impact factor: 2.309

8.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.

Authors:  K K Yu; J Scheidler; H Hricak; D B Vigneron; C J Zaloudek; R G Males; S J Nelson; P R Carroll; J Kurhanewicz
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

9.  Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results.

Authors:  Philippe Puech; Nacim Betrouni; Nasr Makni; Anne-Sophie Dewalle; Arnauld Villers; Laurent Lemaitre
Journal:  Int J Comput Assist Radiol Surg       Date:  2008-10-21       Impact factor: 2.924

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315
View more
  7 in total

Review 1.  Clinical and research applications of simultaneous positron emission tomography and MRI.

Authors:  F Fraioli; S Punwani
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

2.  Technical challenges in 3 T magnetic resonance spectroscopic imaging of the prostate-A single-institution experience.

Authors:  Haesun Choi; Michelle Underwood; Piyaporn Boonsirikamchai; Surena Matin; Patricia Troncoso; Jingfei Ma
Journal:  Quant Imaging Med Surg       Date:  2014-08

Review 3.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

Review 4.  Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Authors:  Sonia Gaur; Baris Turkbey
Journal:  Radiol Clin North Am       Date:  2017-11-27       Impact factor: 2.303

5.  A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer.

Authors:  Yang Liu; Xiang Hu; Hongguang Liu; Lihong Bu; Xiaowei Ma; Kai Cheng; Jinbo Li; Mei Tian; Hong Zhang; Zhen Cheng
Journal:  J Nucl Med       Date:  2013-11-06       Impact factor: 10.057

Review 6.  Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Authors:  Francesca V Mertan; Matthew D Greer; Sam Borofsky; Ismail M Kabakus; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Top Magn Reson Imaging       Date:  2016-06

7.  PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.

Authors:  Ibolya Kálmán-Szabó; Judit P Szabó; Viktória Arató; Noémi Dénes; Gábor Opposits; István Jószai; István Kertész; Zita Képes; Anikó Fekete; Dezső Szikra; István Hajdu; György Trencsényi
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.